Immutep (IMMP) Return on Sales (2016 - 2017)
Immutep filings provide 2 years of Return on Sales readings, the most recent being 0.02% for Q2 2017.
- On a quarterly basis, Return on Sales rose 6.0% to 0.02% in Q2 2017 year-over-year; TTM through Jun 2017 was 0.03%, a N/A change, with the full-year FY2025 number at 0.06%, changed 0.0% from a year prior.
- Return on Sales hit 0.02% in Q2 2017 for Immutep, down from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q1 2017 to a low of 0.08% in Q1 2016.